| Extremely high mutation rate of HIV-1 in vivo JM Cuevas, R Geller, R Garijo, J López-Aldeguer, R Sanjuán PLoS biology 13 (9), e1002251, 2015 | 521 | 2015 |
| The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions S Tam, R Geller, C Spiess, J Frydman Nature cell biology 8 (10), 1155-1162, 2006 | 374 | 2006 |
| Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance R Geller, M Vignuzzi, R Andino, J Frydman Genes & development 21 (2), 195-205, 2007 | 304 | 2007 |
| Broad action of Hsp90 as a host chaperone required for viral replication R Geller, S Taguwa, J Frydman Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1823 (3), 698-706, 2012 | 252 | 2012 |
| Single-cell analysis of RNA virus infection identifies multiple genetically diverse viral genomes within single infectious units M Combe, R Garijo, R Geller, JM Cuevas, R Sanjuán Cell host & microbe 18 (4), 424-432, 2015 | 100 | 2015 |
| The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer SI Khakoo, R Geller, S Shin, JA Jenkins, P Parham The Journal of experimental medicine 196 (7), 911-921, 2002 | 93 | 2002 |
| SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients R Gozalbo-Rovira, E Gimenez, V Latorre, C Frances-Gomez, E Albert, ... Journal of Clinical Virology 131, 104611, 2020 | 87 | 2020 |
| Hsp90 shapes protein and RNA evolution to balance trade-offs between protein stability and aggregation R Geller, S Pechmann, A Acevedo, R Andino, J Frydman Nature communications 9 (1), 1781, 2018 | 72 | 2018 |
| Hsp90 inhibitors exhibit resistance-free antiviral activity against respiratory syncytial virus R Geller, R Andino, J Frydman PloS one 8 (2), e56762, 2013 | 68 | 2013 |
| Highly heterogeneous mutation rates in the hepatitis C virus genome R Geller, Ú Estada, JB Peris, I Andreu, JV Bou, R Garijo, JM Cuevas, ... Nature Microbiology 1 (7), 1-7, 2016 | 61 | 2016 |
| The external domains of the HIV-1 envelope are a mutational cold spot R Geller, P Domingo-Calap, JM Cuevas, P Rossolillo, M Negroni, ... Nature communications 6 (1), 8571, 2015 | 59 | 2015 |
| Potential influence of helminth molecules on COVID-19 pathology M Siles-Lucas, J González-Miguel, R Geller, R Sanjuan, J Pérez-Arévalo, ... Trends in parasitology 37 (1), 11-14, 2021 | 55 | 2021 |
| Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays A Valdivia, I Torres, V Latorre, C Francés-Gómez, E Albert, ... European Journal of Clinical Microbiology & Infectious Diseases 40, 485-494, 2021 | 47 | 2021 |
| Membrane-associated enteroviruses undergo intercellular transmission as pools of sibling viral genomes JV Bou, R Geller, R Sanjuán Cell reports 29 (3), 714-723. e4, 2019 | 36 | 2019 |
| Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjects CT Chan, RE Reeves, R Geller, SS Yaghoubi, A Hoehne, ... Proceedings of the National Academy of Sciences 109 (37), E2476-E2485, 2012 | 35 | 2012 |
| The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation T Ginex, C Marco-Marín, M Wieczór, CP Mata, J Krieger, ... PLoS Pathogens 18 (7), e1010631, 2022 | 30 | 2022 |
| Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the comirnaty COVID-19 vaccine in nursing home residents B Sánchez-Sendra, E Albert, J Zulaica, I Torres, E Giménez, P Botija, ... Scientific Reports 12 (1), 3788, 2022 | 30 | 2022 |
| Increased RNA virus population diversity improves adaptability F Mattenberger, M Vila-Nistal, R Geller Scientific reports 11 (1), 6824, 2021 | 22 | 2021 |
| Severe acute respiratory syndrome coronavirus 2 adaptive immunity in nursing home residents following a third dose of the comirnaty coronavirus disease 2019 vaccine E Giménez, E Albert, J Zulaica, I Torres, L Rusu, AR Moreno, JS Burgos, ... Clinical Infectious Diseases 75 (1), e865-e868, 2022 | 20* | 2022 |
| Globally defining the effects of mutations in a picornavirus capsid F Mattenberger, V Latorre, O Tirosh, A Stern, R Geller Elife 10, e64256, 2021 | 20 | 2021 |
